Result of General Meeting
RNS Number : 4568R
ValiRx PLC
19 November 2012
19 November 2012
VALIRX PLC
("ValiRx" or the "Company")
RESULT OF GENERAL MEETING
ValiRx (AIM: VAL), a life science company with a focus on cancer diagnostics and therapeutics for personalised medicine, announces that at the General Meeting of the Company held earlier today, all resolutions were duly passed.
Enquires:
|
ValiRx plc |
Tel: +44 (0) 20 3008 4416 |
|
Dr Satu Vainikka |
|
|
|
|
|
Cairn Financial Advisers LLP (Nominated Adviser) |
Tel:+44 (0) 20 7148 7900 |
|
Liam Murray / Avi Robinson |
|
|
|
|
|
Hybridan LLP (Broker) |
Tel: +44 (0) 20 7947 4350 |
|
Claire Noyce / Deepak Reddy |
|
|
|
|
|
Peckwater PR |
Tel: +44 (0)7879 458 364 |
|
Tarquin Edwards |
This information is provided by RNS
The company news service from the London Stock Exchange
Latest directors dealings
- 6 hours ago Berkeley Group Holdings (The)
- 7 hours ago JPMorgan Japanese Inv Trust
- 7 hours ago Georgia Capital
- 7 hours ago PureTech Health
- 7 hours ago Barclays